Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Cardiology
General Rheumatology
Questions discussed in this category
How would you manage cardiac sarcoid with intolerance/contraindications to methotrexate, azathioprine, and mycophenolate/mycophenolic acid and that has proven refractory to adalimumab and infliximab as determined by PET?
2 Answers available
Is there utility in obtaining pericardial fluid autoimmune labs such as ANA or RF in patients with recurrent idiopathic pericardial effusions, but no other clinical or serologic evidence of rheumatic disease?
1 Answer available
What is your approach to tapering therapy in a patient with recurrent pericarditis now well-controlled on rilonacept?
2 Answers available
Given the "LDL Paradox", in which RA patients with the highest levels of inflammation can have ultra-low levels of LDL (<70), how do you approach initiation of statin therapy in these patients?
Dr. Charles-Schoeman presented data at ACR 21 showing that, paradoxically, there is a U-shaped relationship between inflammation and LDL levels in pat...
1 Answer available
20532
15437
14469
11281
Papers discussed in this category
N Engl J Med, 2020 Nov 16
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.
International journal of cardiology. Heart & vasculature, 2021 Apr 29
Non-steroidal treatment of cardiac sarcoidosis: A systematic review.
Related Topics in Cardiology
Lung Cancer
Breast Cancer
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Gastrointestinal Cancers
Genitourinary Cancers
Pediatric Hematology/Oncology
Radiation Physics